WAVE Life Sciences Ltd.
WVE
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Wave Life Sciences Ltd. is a clinical-stage genetic medicines company whose drug development pipeline relies on animal testing to advance therapeutic candidates. The company's public research disclosures, including papers in the Journal of Nucleic Acids Research and its 2021 financial report, explicitly highlight data from "a multitude of in vitro and in vivo (animal) studies." This indicates animal models are integral to its preclinical research and regulatory submission process.
As a biopharmaceutical firm developing oligonucleotide therapies for neurological and metabolic diseases, Wave Life Sciences operates in a sector where animal testing is currently mandated by global health authorities for safety and efficacy evaluation prior to human trials. The company's collaborations with major pharmaceutical partners like Takeda and GSK further involve preclinical work that necessitates animal data. This places the company within the exclusion category for commissioning and relying on animal testing as part of its core product development activities.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.